Cited by 4,010Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid MetabolismLipoproteins and Cardiovascular Health

The DOI matches its Crossref record; 99 of the 100 references it cites were found in a registry or an index.

Progress and challenges in translating the biology of atherosclerosis

Libby, Peter, Ridker, Paul M, Hansson, Göran K.·2011·Nature

DOI 10.1038/nature10146

Open this paper in CoChat — free account

Abstract

Atherosclerosis is a chronic disease of the arterial wall, and a leading cause of death and loss of productive life years worldwide. Research into the disease has led to many compelling hypotheses about the pathophysiology of atherosclerotic lesion formation and of complications such as myocardial infarction and stroke. Yet, despite these advances, we still lack definitive evidence to show that processes such as lipoprotein oxidation, inflammation and immunity have a crucial involvement in human atherosclerosis. Experimental atherosclerosis in animals furnishes an important research tool, but extrapolation to humans requires care. Understanding how to combine experimental and clinical science will provide further insight into atherosclerosis and could lead to new clinical applications.

Integrity signals

Registry

Crossref · 10.1038/nature10146

Cites

99 of 99 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Toll-Like Receptor 2 Mediates Apolipoprotein CIII–Induced Monocyte Activation: Retracted
Kawakami, A., Osaka, M., Aikawa, M., Uematsu, S., Akira, S., Libby, P., Shimokado, K., Sacks, F. M., & Yoshida, M. (2008) · Circulation Research · doi:10.1161/circresaha.108.178426 · Cited by 76
Self-citation
Retracted
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Self-citation
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Self-citation
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., Joyal, S. V., Hill, K. A., Pfeffer, M. A., & Skene, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040583 · Cited by 4,938
Atherosclerosis
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881 · cited 1×
“Clinical trials of one agent with PPAR-α-stimulating activity, gemfibrozil, have shown a reduction in cardiovascular event”
Background
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J. J., Gotto, A. M., Kastelein, J. J. P., Köenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Self-citation

Show all 100 references

Sorted by citations

Items 101–200 of 1,007

Mechanistic Insight into Oxidative Stress-Triggered Signaling Pathways and Type 2 Diabetes
Singh, A., Kukreti, R., Saso, L., & Kukreti, S. (2022) · Molecules · doi:10.3390/molecules27030950 · Cited by 354
Clustering of depression and inflammation in adolescents previously exposed to childhood adversity
Miller, G. E., & Cole, S. W. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.02.034 · Cited by 331
Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study
McInnes, I. B., Thompson, L., Giles, J. T., Bathon, J. M., Salmon, J. E., Beaulieu, A. D., Codding, C. E., Carlson, T. H., Delles, C., Lee, J. S., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204345 · Cited by 336
Pyroptosis and its relationship to atherosclerosis
Xu, Y., Zheng, L., Hu, Y., & Wang, Q. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.11.005 · Cited by 326
The mutual interplay of gut microbiota, diet and human disease
Illiano, P., Brambilla, R., & Parolini, C. (2020) · FEBS Journal · doi:10.1111/febs.15217 · Cited by 338
The antioxidant paradox: less paradoxical now?
Halliwell, B. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04272.x · Cited by 318
The Role of Oxidized Low-Density Lipoproteins in Atherosclerosis: The Myths and the Facts
Maiolino, G., Rossitto, G., Caielli, P., Bisogni, V., Rossi, G. P., & Calò, L. A. (2013) · Mediators of Inflammation · doi:10.1155/2013/714653 · Cited by 326
Pathophysiology of Cardiovascular Diseases: New Insights into Molecular Mechanisms of Atherosclerosis, Arterial Hypertension, and Coronary Artery Disease
Frąk, W., Wojtasińska, A., Lisińska, W., Młynarska, E., Franczyk, B., & Rysz, J. (2022) · Biomedicines · doi:10.3390/biomedicines10081938 · Cited by 284
Abnormal High-Density Lipoprotein Induces Endothelial Dysfunction via Activation of Toll-like Receptor-2
Speer, T., Rohrer, L., Blyszczuk, P., Shroff, R., Kuschnerus, K., Kränkel, N., Kania, G., Zewinger, S., Akhmedov, A., Shi, Y., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.009 · Cited by 310
Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment
Choy, E., Ganeshalingam, K., Semb, A. G., Szekanecz, Z., & Nurmohamed, M. T. (2014) · Rheumatology · doi:10.1093/rheumatology/keu224 · Cited by 310
B Cells and Humoral Immunity in Atherosclerosis
Tsiantoulas, D., Diehl, C. J., Witztum, J. L., & Binder, C. J. (2014) · Circulation Research · doi:10.1161/circresaha.113.301145 · Cited by 297
Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway
Geng, J., Yang, C., Wang, B., Zhang, X., Hu, T., Gu, Y., & Li, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.016 · Cited by 297
Of Mice, Dirty Mice, and Men: Using Mice To Understand Human Immunology
Masopust, D., Sivula, C. P., & Jameson, S. C. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700453 · Cited by 315
Acute Coronary Events
Arbab‐Zadeh, A., Nakano, M., Virmani, R., & Fuster, V. (2012) · Circulation · doi:10.1161/circulationaha.111.047431 · Cited by 292
Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
Porez, G., Prawitt, J., Gross, B. S., & Staels, B. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r024794 · Cited by 301
A healthy approach to dietary fats: understanding the science and taking action to reduce consumer confusion
Liu, A. G., Ford, N. A., Hu, F. B., Zelman, K. M., Mozaffarian, D., & Kris‐Etherton, P. M. (2017) · Nutrition Journal · doi:10.1186/s12937-017-0271-4 · Cited by 325
Adiposity and Insulin Resistance in Humans: The Role of the Different Tissue and Cellular Lipid Depots
HOCKING, S. L., Samocha‐Bonet, D., Milner, K., Greenfield, J. R., & Chisholm, D. J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1041 · Cited by 295
Anthocyanins: From Sources and Bioavailability to Cardiovascular-Health Benefits and Molecular Mechanisms of Action
Krga, I., & Milenković, D. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b06737 · Cited by 285
Role of immune cells in obesity induced low grade inflammation and insulin resistance
Asghar, A., & Sheikh, N. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.03.001 · Cited by 278
Role of biomechanical forces in the natural history of coronary atherosclerosis
Brown, A. J., Teng, Z., Evans, P. C., Gillard, J. H., Samady, H., & Bennett, M. R. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.203 · Cited by 279
Lysine acetyltransferases and lysine deacetylases as targets for cardiovascular disease
Li, P., Ge, J., & Li, H. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0235-9 · Cited by 269
Acute and chronic psychological stress as risk factors for cardiovascular disease: Insights gained from epidemiological, clinical and experimental studies
Lagraauw, H. M., Kuiper, J., & Bot, I. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.08.007 · Cited by 289
Splenic Metabolic Activity Predicts Risk of Future Cardiovascular Events
Emami, H., Singh, P., MacNabb, M. H., Vucic, E., Lavender, Z. R., Rudd, J. H. F., Fayad, Z. A., Lehrer‐Graiwer, J., Korsgren, M., Figueroa, A. L., et al. (2015) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2014.10.009 · Cited by 263
The Core Mechanism of Dry Eye Disease Is Inflammation
Wei, Y., & Asbell, P. A. (2014) · Eye & Contact Lens Science & Clinical Practice · doi:10.1097/icl.0000000000000042 · Cited by 263
Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis
Ridker, P. M. (2019) · Circulation Research · doi:10.1161/circresaha.118.313129 · Cited by 260
Self-citation
Foam Cells in Atherosclerosis: Novel Insights Into Its Origins, Consequences, and Molecular Mechanisms
Gui, Y., Zheng, H., & Cao, R. Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.845942 · Cited by 258
Heart in space: effect of the extraterrestrial environment on the cardiovascular system
Hughson, R. L., Helm, A., & Durante, M. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.157 · Cited by 257
The Review of Current Knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL)
Romejko, K., Markowska, M., & Niemczyk, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310470 · Cited by 264
Genetically Determined Levels of Circulating Cytokines and Risk of Stroke
Georgakis, M. K., Gill, D., Rannikmäe, K., Traylor, M., Anderson, C. D., Lee, J., Kamatani, Y., Hopewell, J. C., Worrall, B. B., Bernhagen, J., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.035905 · Cited by 248
The Role of Exosomes and Exosomal MicroRNA in Cardiovascular Disease
Zheng, D., Huo, M., Li, B., Wang, W., Piao, H., Wang, Y., Zhu, Z., Li, D., Wang, T., & Liu, K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.616161 · Cited by 251
Comprehensive Metabolomic Characterization of Coronary Artery Diseases
Fan, Y., Li, Y., Chen, Y., Zhao, Y., Liu, L., Li, J., Wang, S.-L., Alolga, R. N., Yin, Y., Wang, X., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.044 · Cited by 249
Inflammation, Frailty and Cardiovascular Disease
Soysal, P., Arık, F., Smith, L., Jackson, S. E., & Işık, A. T. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-33330-0_7 · Cited by 256
Pathogenesis of Acute Coronary Syndromes
Crea, F., & Liuzzo, G. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.064 · Cited by 247
Inflammation, Endoplasmic Reticulum Stress, Autophagy, and the Monocyte Chemoattractant Protein-1/CCR2 Pathway
Kolattukudy, P. E., & Niu, J. (2012) · Circulation Research · doi:10.1161/circresaha.111.243212 · Cited by 249
Recent Advances of Activatable Molecular Probes Based on Semiconducting Polymer Nanoparticles in Sensing and Imaging
Lyu, Y., & Pu, K. (2017) · Advanced Science · doi:10.1002/advs.201600481 · Cited by 247
Sleep duration, cardiovascular disease, and proinflammatory biomarkers
Grandner, M., Sands-Lincoln, Pak, & Garland (2013) · Nature and Science of Sleep · doi:10.2147/nss.s31063 · Cited by 246
The Cardioprotective Protein Apolipoprotein A1 Promotes Potent Anti-tumorigenic Effects
Zamanian-Daryoush, M., Lindner, D. J., Tallant, T. C., Wang, Z., Buffa, J. A., Klipfell, E., Parker, Y., Hatala, D. A., Parsons‐Wingerter, P. A., Rayman, P. A., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.468967 · Cited by 250
Heme Oxygenases in Cardiovascular Health and Disease
Ayer, A., Zarjou, A., Agarwal, A., & Stocker, R. (2016) · Physiological Reviews · doi:10.1152/physrev.00003.2016 · Cited by 248
Neuroimmune cardiovascular interfaces control atherosclerosis
Mohanta, S. K., Peng, L., Li, Y., Lu, S., Sun, T., Carnevale, L., Perrotta, M., Ma, Z., Förstera, B., Stanic, K., et al. (2022) · Nature · doi:10.1038/s41586-022-04673-6 · Cited by 249
lncRNA/MicroRNA interactions in the vasculature
Ballantyne, M. D., McDonald, R., & Baker, A. H. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.355 · Cited by 242
Plasma Trimethylamine N -Oxide, a Gut Microbe–Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden
Senthong, V., Li, X. S., Hudec, T., Coughlin, J., Wu, Y., Levison, B., Wang, Z., Hazen, S. L., & Tang, W. H. W. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.546 · Cited by 242
Cholesterol crystal induced arterial inflammation and destabilization of atherosclerotic plaque
Janoudi, A., Shamoun, F. E., Kalavakunta, J. K., & Abela, G. S. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv653 · Cited by 243
Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis
Livshits, G., & Kalinkovich, A. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100980 · Cited by 245
Cold Exposure Promotes Atherosclerotic Plaque Growth and Instability via UCP1-Dependent Lipolysis
Dong, M., Yang, X., Lim, S., Cao, Z., Honek, J., Lu, H., Zhang, C., Seki, T., Hosaka, K., Wahlberg, E., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.003 · Cited by 240
Lipoprotein(a) as a Potential Causal Genetic Risk Factor of Cardiovascular Disease
Tsimikas, S., & Hall, J. L. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.038 · Cited by 234
Induction of Lysosomal Biogenesis in Atherosclerotic Macrophages Can Rescue Lipid-Induced Lysosomal Dysfunction and Downstream Sequelae
Emanuel, R., Sergin, I., Bhattacharya, S., Turner, J. N., Epelman, S., Settembre, C., Diwan, A., Ballabio, A., & Razani, B. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303342 · Cited by 236
Selective Insulin Resistance and the Development of Cardiovascular Diseases in Diabetes: The 2015 Edwin Bierman Award Lecture
King, G. L., Park, K., & Li, Q. (2016) · Diabetes · doi:10.2337/db16-0152 · Cited by 232
Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation
Tang, J., Lobatto, M. E., Hassing, L., van der Staay, S. E. M., van Rijs, S. M., Calcagno, C., Braza, M. S., Baxter, S., Fay, F., Sánchez-Gaytán, B. L., et al. (2015) · Science Advances · doi:10.1126/sciadv.1400223 · Cited by 228
Programmed cell death in atherosclerosis and vascular calcification
Li, M., Wang, Z., Fang, L., Cheng, S.-Q., Wang, X., & Liu, N. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04923-5 · Cited by 243
Non-genetic engineering of cells for drug delivery and cell-based therapy
Wang, Q., Cheng, H., Peng, H., Zhou, H., Li, P. Y., & Langer, R. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.12.003 · Cited by 225
Atherosclerosis – A matter of unresolved inflammation
Viola, J. R., & Soehnlein, O. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.013 · Cited by 229
Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis
Linton, M. F., Babaev, V. R., Huang, J., Linton, E. F., Tao, H., & Yancey, P. G. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0924 · Cited by 235
Gut Parabacteroides merdae protects against cardiovascular damage by enhancing branched-chain amino acid catabolism
Qiao, S., Liu, C., Sun, L., Wang, T., Dai, H., Wang, K., Li, B., Li, H., Wang, W., Liu, S., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00649-y · Cited by 231
Colchicine Use Is Associated with Decreased Prevalence of Myocardial Infarction in Patients with Gout
Crittenden, D. B., Lehmann, R. A., SCHNECK, L., Keenan, R. T., Shah, B., Greenberg, J. D., Cronstein, B. N., Sedlis, S. P., & Pillinger, M. H. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.111533 · Cited by 226
Inflammation and Stroke Risk: A New Target for Prevention
Kelly, P. J., Lemmens, R., & Tsivgoulis, G. K. (2021) · Stroke · doi:10.1161/strokeaha.121.034388 · Cited by 218
Mitochondrial Reactive Oxygen Species Mediate Lysophosphatidylcholine-Induced Endothelial Cell Activation
Li, X., Fang, P., Li, Y., Kuo, Y., Andrews, A. J., Nanayakkara, G., Johnson, C., Fu, H., Shan, H., Du, F., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306964 · Cited by 220
Oxidation-Specific Biomarkers, Prospective 15-Year Cardiovascular and Stroke Outcomes, and Net Reclassification of Cardiovascular Events
Tsimikas, S., Willeit, P., Willeit, J., Santer, P., Mayr, M., Xu, Q., Mayr, A., Witztum, J. L., & Kiechl, S. J. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.979 · Cited by 219
Endoplasmic Reticulum Stress in Metabolic Disorders
Ghemrawi, R., Battaglia-Hsu, S.-F., & Arnold, C. (2018) · Cells · doi:10.3390/cells7060063 · Cited by 227
Hypoxia inducible factor as a therapeutic target for atherosclerosis
Jain, T., Nikolopoulou, E. A., Xu, Q., & Qu, A. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.09.003 · Cited by 216
Role of long non-coding RNA-RNCR3 in atherosclerosis-related vascular dysfunction
Shan, K., Jiang, Q. L., Wang, X. Q., Wang, Y. N. Z., Yang, H., Yao, M. D., Liu, C., Li, X., Yao, J., Liu, B., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.145 · Cited by 216
Monocyte Fate in Atherosclerosis
Hilgendorf, I., Świrski, F. K., & Robbins, C. S. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303565 · Cited by 222
Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases
Tijsen, A. J., Pinto, Y. M., & Creemers, E. E. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00191.2012 · Cited by 213
Targeting monocytes/macrophages in the treatment of rheumatoid arthritis
Davignon, J.-L., Hayder, M., Baron, M., Boyer, J.-F., Constantin, A., Apparailly, F., Poupot, R., & Cantagrel, A. (2013) · Rheumatology · doi:10.1093/rheumatology/kes304 · Cited by 209
Integrin beta3 regulates clonality and fate of smooth muscle-derived atherosclerotic plaque cells
Misra, A., Feng, Z., Chandran, R. R., Kabir, I., Rotllan, N., Aryal, B., Sheikh, A. Q., Ding, L., Qin, L., Fernández-Hernando, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04447-7 · Cited by 207
Early Hyperlipidemia Promotes Endothelial Activation via a Caspase-1-Sirtuin 1 Pathway
Yin, Y., Li, X., Sha, X., Xi, H., Li, Y., Shao, Y., Mai, J., Virtue, A. T., Lopez‐Pastrana, J., Meng, S., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305282 · Cited by 207
Familial Hypercholesterolemia and Atherosclerosis in Cloned Minipigs Created by DNA Transposition of a Human PCSK9 Gain-of-Function Mutant
Al-Mashhadi, R. H., Sørensen, C. B., Kragh, P. M., Christoffersen, C., Mortensen, M. B., Tolbod, L. P., Thim, T., Du, Y., Li, J., Liu, Y., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004853 · Cited by 207
HMOX1 upregulation promotes ferroptosis in diabetic atherosclerosis
Meng, Z., Liang, H., Zhao, J., Gao, J., Liu, C., Ma, X., Liu, J., Liang, B., Jiao, X., Cao, J.-M., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119935 · Cited by 205
Detection by Near-Infrared Spectroscopy of Large Lipid Core Plaques at Culprit Sites in Patients With Acute ST-Segment Elevation Myocardial Infarction
Madder, R. D., Goldstein, J. A., Madden, S., Puri, R., Wolski, K., Hendricks, M. J., Sum, S. T., Kini, A. S., Sharma, S., Rizik, D. G., et al. (2013) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2013.04.012 · Cited by 205
Inflammation induces endothelial‐to‐mesenchymal transition and promotes vascular calcification through downregulation of BMPR2
Sánchez‐Duffhues, G., de Vinuesa, A. G., van de Pol, V., Geerts, M., de Vries, M. R., Janson, S. G. T., van Dam, H., Lindeman, J. H. N., Goumans, M., & ten Dijke, P. (2018) · The Journal of Pathology · doi:10.1002/path.5193 · Cited by 200
Endothelial dysfunction in rheumatic autoimmune diseases
Murdaca, G., Colombo, B. M., Cagnati, P., Gulli, R., Spanò, F. M., & Puppo, F. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.05.013 · Cited by 199
Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: A systematic review and meta-analysis
Liao, H.-W., Saver, J. L., Wu, Y.-L., Chen, T.-H., Lee, M., & Ovbiagele, B. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013927 · Cited by 198
Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis
Murphy, A. J., Bijl, N., Yvan‐Charvet, L., Welch, C. L., Bhagwat, N., Adili, R., Wang, Y., Shaw, J. A., Levine, R. L., Ni, H., et al. (2013) · Nature Medicine · doi:10.1038/nm.3150 · Cited by 201
Pathogenesis of atherosclerosis in the tunica intima, media, and adventitia of coronary arteries: An updated review
Milutinović, A., Šuput, D., & Zorc‐Pleskovič, R. (2019) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2019.4320 · Cited by 200
Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases
Pala, R., Anju, V. T., Dyavaiah, M., Busi, S., & Nauli, S. M. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s250872 · Cited by 213
Transforming Growth Factor–β Signaling in T Cells Promotes Stabilization of Atherosclerotic Plaques Through an Interleukin-17–Dependent Pathway
Gisterå, A., Robertson, A.-K. L., Andersson, J., Ketelhuth, D. F. J., Овчинникова, О. А., Nilsson, S. K., Lundberg, A. M., Li, M. O., Flavell, R. A., & Hansson, G. K. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006133 · Cited by 194
Self-citation
Preterm Delivery and Maternal Cardiovascular Disease in Young and Middle-Aged Adult Women
Tanz, L. J., Stuart, J. J., Williams, P. L., Rimm, E. B., Missmer, S. A., Rexrode, K. M., Mukamal, K. J., & Rich-Edwards, J. W. (2017) · Circulation · doi:10.1161/circulationaha.116.025954 · Cited by 194
Imaging and Nanomedicine in Inflammatory Atherosclerosis
Mulder, W. J. M., Jaffer, F. A., Fayad, Z. A., & Nahrendorf, M. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3005101 · Cited by 200
Cellular Crosstalk between Endothelial and Smooth Muscle Cells in Vascular Wall Remodeling
Méndez‐Barbero, N., Gutiérrez‐Muñoz, C., & Blanco‐Colio, L. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147284 · Cited by 206
Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota
Ma, S., Tong, Q., Lin, Y., Pan, L., Fu, J., Peng, R., Zhang, X., Zhao, Z., Li, Y., Yu, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01027-6 · Cited by 197
The Obesity Epidemic: The USA as a Cautionary Tale for the Rest of the World
Imes, C. C., & Burke, L. E. (2014) · Current Epidemiology Reports · doi:10.1007/s40471-014-0012-6 · Cited by 187
The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/–/ApoE–/– mice
Mercer, J. R., Yu, E., Figg, N. L., Cheng, K., Prime, T. A., Griffin, J. L., Masoodi, M., Vidal‐Puig, A., Murphy, M. P., & Bennett, M. R. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.026 · Cited by 188
A glance at the therapeutic potential of irisin against diseases involving inflammation, oxidative stress, and apoptosis: An introductory review
Askari, H., Rajani, S. F., Poorebrahim, M., Haghi‐Aminjan, H., Raeis-Abdollahi, E., & Abdollahi, M. R. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.012 · Cited by 191
The accelerated aging phenotype: The role of race and social determinants of health on aging
Hooten, N. N., Pacheco, N. L., Smith, J. T., & Evans, M. K. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101536 · Cited by 199
Interleukin-17A Deficiency Accelerates Unstable Atherosclerotic Plaque Formation in Apolipoprotein E-Deficient Mice
Danzaki, K., Matsui, Y., Ikesue, M., Ohta, D., Ito, K., Kanayama, M., Kurotaki, D., Morimoto, J. O., Iwakura, Y., Yagita∥, H., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.229997 · Cited by 187
Neutrophil Extracellular Traps and Endothelial Dysfunction in Atherosclerosis and Thrombosis
Qi, H., Yang, S., & Zhang, L. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00928 · Cited by 192
Exosomes in atherosclerosis: performers, bystanders, biomarkers, and therapeutic targets
Wang, C., Li, Z., Liu, Y., & Yuan, L. (2021) · Theranostics · doi:10.7150/thno.56035 · Cited by 194
Glucagon-Like Peptide-1 (GLP-1) Analog Liraglutide Inhibits Endothelial Cell Inflammation through a Calcium and AMPK Dependent Mechanism
Krasner, N. M., Ido, Y., Ruderman, N. B., & Cacicedo, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097554 · Cited by 186
From Detecting the Vulnerable Plaque to Managing the Vulnerable Patient
Arbab‐Zadeh, A., & Fuster, V. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.062 · Cited by 187
Targeting smooth muscle cell phenotypic switching in vascular disease
Chakraborty, R., Chatterjee, P., Dave, J. M., Ostriker, A. C., Greif, D. M., Rzucidlo, E. M., & Martin, K. A. (2021) · JVS Vascular Science · doi:10.1016/j.jvssci.2021.04.001 · Cited by 182
Hematopoiesis and Cardiovascular Disease
Poller, W. C., Nahrendorf, M., & Świrski, F. K. (2020) · Circulation Research · doi:10.1161/circresaha.120.315895 · Cited by 191
Psoriasis Is a Systemic Disease with Multiple Cardiovascular and Metabolic Comorbidities
Ryan, C., & Kirby, B. (2014) · Dermatologic Clinics · doi:10.1016/j.det.2014.09.004 · Cited by 182
Inflammatory Biomarkers and Atherosclerosis
Soeki, T., & Sata, M. (2016) · International Heart Journal · doi:10.1536/ihj.15-346 · Cited by 183
Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment
He, Z., Chen, W., Hu, K., Luo, Y., Zeng, W., He, X., Li, T., Ouyang, J., Li, Y., Xie, L., et al. (2024) · Nature Nanotechnology · doi:10.1038/s41565-024-01687-1 · Cited by 191
The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?
Miller, V. M., Naftolin, F. N., Asthana, S., Black, D. M., Brinton, E. A., Budoff, M. J., Cedars, M. I., Dowling, N. M., Gleason, C. E., Hodis, H. N., et al. (2019) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001326 · Cited by 188
Mouse Models for Atherosclerosis Research—Which Is My Line?
Oppi, S., Lüscher, T. F., & Stein, S. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00046 · Cited by 195
Vascular Smooth Muscle Cells Phenotypic Switching in Cardiovascular Diseases
Tang, H., Chen, A., Zhang, H., Gao, X., Kong, X., & Zhang, J. (2022) · Cells · doi:10.3390/cells11244060 · Cited by 177
Hyperglycemia and Endothelial Dysfunction in Atherosclerosis: Lessons from Type 1 Diabetes
Funk, S. D., Yurdagul, A., & Orr, A. W. (2012) · International Journal of Vascular Medicine · doi:10.1155/2012/569654 · Cited by 176
Adverse Epigenetic Signatures by Histone Methyltransferase Set7 Contribute to Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus
Paneni, F., Costantino, S., Battista, R., Castello, L., Capretti, G., Chiandotto, S., Scavone, G., Villano, A., Pitocco, D., Lanza, G. A., et al. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.114.000671 · Cited by 177
Multiple cell types contribute to the atherosclerotic lesion fibrous cap by PDGFRβ and bioenergetic mechanisms
Newman, A. A. C., Serbulea, V., Baylis, R. A., Shankman, L. S., Bradley, X., Alencar, G. F., Owsiany, K. M., Deaton, R. A., Karnewar, S., Shamsuzzaman, S., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-020-00338-8 · Cited by 176
Role of miR-181 family in regulating vascular inflammation and immunity
Sun, X., Sit, A., & Feinberg, M. W. (2013) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2013.09.002 · Cited by 177

Authors: Libby, P., Ridker, P. M., & Hansson, G. K.
Affiliations: Brigham and Women's Hospital (US)
Karolinska University Hospital (SE)
Corresponding author: Libby, Peter
ORCID: Libby, Peter
Ridker, Paul M
Hansson, Göran K.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2011-05
Volume: 473
Issue: 7347
Pages: 317-325
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature10146
OpenAlex: W2033896075
Semantic Scholar: 31a83a618339a5f25357342f3633f5a423880eb6
Cited by: 4,010
References: 100
Citations by year: 2026: 169 · 2025: 235 · 2024: 252 · 2023: 249 · 2022: 283 · 2021: 342 · 2020: 299 · 2019: 264 · 2018: 271 · 2017: 304 · 2016: 271 · 2015: 286 · 2014: 258 · 2013: 232 · 2012: 230
FWCI: 22.29
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords: atherosclerosis, atherosclerotic plaque formation, lipoprotein oxidation, inflammation, immunity, animal models, animal-to-human extrapolation, myocardial infarction, stroke, translational research
MeSH terms: Animals, Humans, Inflammation, Cholesterol, HDL, Cholesterol, LDL, Triglycerides, Atherosclerosis, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Progress and challenges in translating the biology of atherosclerosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks